Revenue of Johnson & Johnson's pharmaceuticals segment worldwide 2012-2024

In 2018, Johnson & Johnson generated over 12 billion U.S. dollars in revenue through immunology products. Revenue from this product category is projected to decrease in the coming years, while earnings from the oncology category are set to increase.

Johnson & Johnson’s total revenue

Johnson & Johnson’s global revenue came to some 82 billion U.S. dollars in 2019 – although this is the total revenue from all three of the company’s segments. Over the past decade, the company’s total revenue numbers have increased by almost 22 percent. The multinational, headquartered in New Jersey, earns roughly half of that revenue in its home market: in 2018, J&J generated close to 42 billion U.S. dollars in the United States. A total of approximately 15 billion U.S. dollars were made in the African and Asian Pacific regions that year.

J&J WORKFORCE

In 2017, J&J’s workforce count had, for the first time, reached and exceeded the 130 thousand mark. In 2018 specifically, just over 135 thousand people worked for Johnson & Johnson. These employees are active in various areas in over 60 countries worldwide: from pharmaceutical R&D to manufacturing and sales.